Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQPX2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,317
Award facts
- Contract value 100% obligated
- $69,316.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $69,316.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The delivery order, issued on December 10, 2025, with an ultimate completion date of January 2, 2026, carries no set-aside designation and represents a competitive award to a vendor capable of meeting unrestricted federal procurement requirements. DMS Pharmaceutical Group is performing work at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical and medical consumable procurement for Department of Defense healthcare operations. The underlying contract, valued at $499,999,999 and effective through December 31, 2036, authorizes DLA to issue delivery orders for branded and generic pharmaceuticals, biologics, and medical supplies to support military medical facilities worldwide. DMS Pharmaceutical Group's demonstrated performance across numerous prior delivery orders establishes its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQPX2?
SPE2DR26FQPX2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FQPX2 worth?
The government has obligated $69,317 on SPE2DR26FQPX2.
Is contract SPE2DR26FQPX2 an order under another contract?
Yes. SPE2DR26FQPX2 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.
Was contract SPE2DR26FQPX2 competed?
The extent of competition for SPE2DR26FQPX2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award